Today: 9 June 2026
Cisco stock rises after Silicon One G300 AI chip launch, with earnings next

Cisco stock rises after Silicon One G300 AI chip launch, with earnings next

New York, Feb 10, 2026, 12:14 PM EST — Regular session

  • Cisco shares gained on Tuesday after the company rolled out a new AI networking chip alongside a router.
  • This launch puts Cisco toe-to-toe with Nvidia and Broadcom in the data-center networking arena.
  • Cisco’s quarterly report lands this week, and investors are watching closely.

Cisco Systems stock edged up roughly 0.7% to $87.35 around midday Tuesday, with investors reacting to the debut of a new AI-centric switch chip and a data center router. The company introduced the Silicon One G300, built using Taiwan Semiconductor Manufacturing Co’s 3-nanometer technology. Cisco claims the chip can route network data in microseconds, aiming to keep AI networks running smoothly even during sudden traffic spikes—and says that could deliver AI workload speed gains up to 28%. The G300 is slated to hit the market in the second half. “We focus on the total end-to-end efficiency of the network,” said Martin Lund, executive vice president of Cisco’s common hardware group, in comments to Reuters. Reuters

Investors are tracking the next phase of AI spending, just as this product push hits. Network gear has become a bottleneck, with companies scrambling to link up ever-larger processor clusters—forcing both chipmakers and equipment suppliers into the tussle.

At Cisco Live EMEA in Amsterdam, Cisco rolled out the G300 alongside fresh Nexus 9000 and Cisco 8000 gear, plus upgraded optics targeting data-center demands, according to the company. The G300 clocks in at 102.4 terabits per second of throughput, Cisco said, and with full liquid cooling, it claims energy efficiency can jump by almost 70% at equivalent bandwidth. “We’re building the foundation for the future of infrastructure,” President and Chief Product Officer Jeetu Patel said. SemiAnalysis founder Dylan Patel, for his part, pointed out that “Networking has been the fundamental constraint to scaling AI.” Cisco Newsroom

Cisco paired its silicon news with updates on “AgenticOps” — think software agents built to suggest or automate IT tasks — spreading across its networking, security, and observability products. Some of those campus, branch, and industrial features hit the market starting in February, the company said, while data-center capabilities are headed for controlled release in June. Splunk AI Agent Monitoring goes generally available Feb. 25. Cisco Newsroom

Shares of Cisco kept up their rally, advancing 2.3% Monday to finish at $86.78—marking a third consecutive session of gains and setting a fresh 52-week high, according to MarketWatch data.

Tuesday’s action saw Nvidia off roughly 0.4%, Broadcom eased by about 0.5%. Arista Networks, on the other hand, gained close to 0.9%.

Traders are watching to see if these product announcements actually drive orders soon enough to show up in the numbers, not just in presentations. Cisco still needs to prove to customers that it can offer reliable performance at scale, especially with major buyers putting every claim to the test.

Still, there’s a wait ahead—the chip won’t land on the market until later this year. Data center design wins don’t tend to materialize quickly, and big clients could keep relying on their existing setups or opt for their own builds unless the cost math works out.

Cisco reports fiscal Q2 numbers after the bell Wednesday, with its conference call scheduled for 4:30 p.m. ET. Investors are watching closely for that update.

Stock Market Today

  • Soybean Prices Dip Amid Export Sales and Crop Progress Reports
    June 9, 2026, 9:20 AM EDT. Soybeans experienced modest declines on Monday, with futures dropping up to 5¾ cents and the national average cash price falling to $10.57 1/2 per bushel. The USDA reported a private sale of 264,000 metric tons for the 2026/27 marketing year. Weekly export shipments fell 21.2%, totaling 398,186 MT, led by Egypt, China, and Mexico. Crop progress shows 92% planted and emergence ahead of schedule, though crop conditions slipped slightly. Marketing year exports remain 20.3% below last year, reflecting pressure on prices. Soymeal futures declined 20 cents, and soy oil futures showed mixed moves. These indicators suggest cautious market sentiment amid ongoing supply and demand factors shaping the soybean market.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
BAT share price slips again as buyback filing lands and Capital Group trims stake ahead of results
Previous Story

BAT share price slips again as buyback filing lands and Capital Group trims stake ahead of results

Legal & General share price slips as AI disruption worries keep UK insurers on edge
Next Story

Legal & General share price slips as AI disruption worries keep UK insurers on edge

Go toTop